Simple Summary This review explores the challenges of drug resistance in cancer treatment
and discusses innovative strategies to overcome them. Researchers aim to understand how …

Prostate cancer (PC) is one of the most common cancers in males and the fifth leading
reason of death. Age, ethnicity, family history, and genetic defects are major factors that …

Chimeric antigen receptor macrophage (CAR-MΦ) represents a significant advancement in
immunotherapy, especially for treating solid tumors where traditional CAR-T therapies face …

Background The FDA's alerts regarding the T-cell lymphoma risk post CAR-T therapy has
garnered global attention, yet a comprehensive profile of second primary malignancies …

Next-generation immunotherapies have revolutionized cancer treatment, offering hope for
patients with hard-to-treat tumors. This review focuses on the clinical applications and …

Pancreatic cancer is a highly lethal solid malignancy with limited treatment options. Chimeric
antigen receptor T (CAR-T) cell therapy has been successfully applied to treat hematological …

Highlights•Bioinspired microrobots offer innovative solutions for brain-targeted cancer
therapy.•These microrobots navigate the blood–brain barrier for precise drug delivery.• …

Chimeric antigen receptor‐natural killer (CAR‐NK) cell therapy is emerging as a promising
cancer treatment, with notable safety and source diversity benefits over CAR‐T cells. This …

Chimeric antigen receptor-T (CAR-T) cell therapy has made remarkable strides in treating
hematological malignancies. However, the widespread adoption of CAR-T cell therapy is …

Chimeric antigen receptor T (CAR-T) cell therapy, a groundbreaking immunotherapy.
However, it faces formidable challenges in treating solid tumors, grappling with issues like …